Zhejiang Jingxin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 870.57 million compared to CNY 857.51 million a year ago. Revenue was CNY 870.57 million compared to CNY 857.51 million a year ago. Net income was CNY 137.26 million compared to CNY 134.01 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.17 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.17 a year ago.